Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of Eomesodermin to determine risk of allograft rejection

Use of Eomesodermin to determine risk of allograft rejection

US Patent 11022601 · Granted Jun 1, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Controlled release formulations for the induction and proliferation of blood cel2025
Use of eomesodermin to determine risk of allograft rejection2025
Use of eomesodermin to determine risk of allograft rejection2025
Controlled release formulations for the induction and proliferation of blood cel2020
Composition containing immature mammalian dendritic cells for enhancing toleroge2001
Method of regulating dendritic cell maturation1999